Title for MeetingAbstracts
Alphabetical listing of titles
Neutralizing and non-neutralizing monoclonal antibodies are generated by immunization with the principal neutralizing determinant (PND) of HIV-1-MN.
Neutralizing and principal neutralizing determinant-specific binding antibodies to four HIV-1 strains in sera of Japanese hemophiliacs.
Neutralizing and secretory antibody responses to adeno-HIV vaccines in chimpanzees.
Neutralizing antibodies against HIV-1 primary isolates positively correlate with CD4+T lymphocyte counts and T cell function in long-term AIDS-free HIV-1 infected individuals.
Neutralizing antibodies and materno-foetal transmission of HIV-1.
Neutralizing antibodies and noninfectious viral isolates associated with prolonged survival in asymptomatic African children with perinatally HIV-1 infection.
Neutralizing Antibodies Applied to the Mucosal Surface, or Preincubated with Challenge Virus ex Vivo, Fail to Protect Macaques Against SHIV-Challenge.
Neutralizing antibodies as a correlate of vaccine efficacy in the SHIV model.
Neutralizing antibodies effective against multiple HIV-1 isolates specific for conformational-dependent epitopes in HIV-1 gp120.
Neutralizing antibodies generated in macaques immunized with live recombinant vaccinia virus boosted with recombinant-made SIVmne gp160.
Neutralizing antibodies in HIV patients: a 3 year follow up.
Neutralizing antibodies in SIVmac infected macaques in relation to the course of disease.
Neutralizing antibodies to conserved, oligomer dependent epitopes in gp41.
Neutralizing antibodies to HIV-1 in monkeys immunized with a HIV-1 synthetic immunogen representing the antigenic diversity of the envelope glycoprotein in infected humans.
Neutralizing antibody does not prevent perinatal transmission of HIV-1.
Neutralizing antibody does not prevent vertical transmission of HIV-1.
Neutralizing antibody in seropositive subjects from Africa, South and North America against 4 divergent strains of HIV.
Neutralizing antibody responses in humans and animals immunized with intra-subtype B bivalent vaccine AIDSVAX B/B.
Neutralizing Antibody Responses in Subtype-C-infected Heterosexual Seroconvertors in Zambia are Surprisingly High Titer.
Neutralizing Antibody Responses Induced in Rhesus Macaques Using Different DNA Delivery Technologies as Prime and o-gp140deltaDV2 SF162 as Boost.
Neutralizing Antibody Responses Often Persist at High Titers in Chronic HIV Infection but Do Not Exert an Antiviral Effect Against Autologous Virus.
Neutralizing antibody, plasma and cervical viral burden in relation to maternal-infant transmission in northen Thailand.
Neutralizing domain in the external enveope glycoprotein of SIVmac251.
Neutralizing effect of secretory IgA to HIV in parotid saliva of HIV-infected patients.
Neutralizing effects and ADCC in lentiviral infection mediated by bispecific antibody.
Neutralizing epitope of HIV-1: antibody specificity, immunogenicity, and protein localization.
Neutralizing epitopes on primary HIV-1 isolates.
Neutralizing monoclonal antibodies to HHV6 identify virion envelope glycoproteins.
Neutralizing monoclonal antibody against an external envelope protein (gp120) of SIVmac251.
Neutralizing peptides and neutralizable epitopes of HIV-1 env glycoproteins.